Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction.
about
Aliskiren vs. angiotensin receptor blockers in hypertension: meta-analysis of randomized controlled trialsImpact of exercise and dietary fatty acid composition from a high-fat diet on markers of hunger and satiety.The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter studyThe Pol-e-pill finally arrives.Effects of dietary fatty acid composition on 24-h energy expenditure and chronic disease risk factors in menReview the key role of self-efficacy in diabetes care.The role of leptin in obesity and the potential for leptin replacement therapy.Factors affecting circulating levels of peptide YY in humans: a comprehensive review.Cardiovascular risk factors in children and adolescents living in an urban area of Southeast of Brazil: Ouro Preto Study.Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.Serum leptin levels in obese males during over- and underfeeding.
P2860
Q28304657-E4C1C3B3-AABC-454D-AE7C-2E834FBA52E3Q34038913-73E27861-573B-4A4A-9941-72174A9DD150Q34268853-824FC181-D604-4412-93F3-AF6341991BBBQ36555035-05783E82-8CDF-4F5A-8401-13725B0D9374Q36756566-3E2EA5D9-9FDE-4146-A3D8-BA6246E981EAQ37179118-A9106243-20E0-4306-B8D3-86BBBE661383Q37186519-B44D55BD-EA21-440C-921A-ECCF0F9BB07EQ38070350-DBE1F569-1E92-4778-9B19-891297E0C168Q38220576-514C653C-5DE0-4447-ADA1-FFB5CA546BC8Q39875054-7D79D6B9-B467-43EA-98AB-FBE06CDF73B7Q44906282-66F609E0-8BEE-4FDC-A885-AE3DA80C8E13Q47795059-C1A8C08C-D6EC-4DD5-9305-56F927EE3543
P2860
Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular morbidity and m ...... ortunities for risk reduction.
@en
type
label
Cardiovascular morbidity and m ...... ortunities for risk reduction.
@en
prefLabel
Cardiovascular morbidity and m ...... ortunities for risk reduction.
@en
P1476
Cardiovascular morbidity and m ...... ortunities for risk reduction.
@en
P2093
Wanpen Vongpatanasin
P2860
P356
10.1111/J.1524-6175.2007.07722.X
P433
11 Suppl 4
P577
2007-11-01T00:00:00Z